Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Century Therapeutics Inc fell by 36.94m. However, Cash Flow from Investing totalled 61.13m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 88.35m for operations while cash used for financing totalled 9.73m.
Cash flow per share | -1.79 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 2.63 |
---|---|
Tangible book value per share | 2.17 |
More ▼